SenesTech Company historical financials - (NASDAQ:SNES)

SenesTech Financials

SNES Stock  USD 2.25  0.01  0.45%   
SenesTech is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January. At this time, SenesTech's Common Stock Total Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 7.6 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 4.8 M in 2024. Key indicators impacting SenesTech's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio8.918.4898
Sufficiently Up
Slightly volatile
The essential information of the day-to-day investment outlook for SenesTech includes many different criteria found on its balance sheet. An individual investor should monitor SenesTech's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in SenesTech.

Net Income

(8.1 Million)

  
Please note, the imprecision that can be found in SenesTech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of SenesTech. Check SenesTech's Beneish M Score to see the likelihood of SenesTech's management manipulating its earnings.

SenesTech Stock Summary

SenesTech competes with CN Energy, Danimer Scientific, Ecovyst, Alto Ingredients, and Lightwave Logic. SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona. Senestech operates under Specialty Chemicals classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.
Specialization
Basic Materials, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS81720R2085
CUSIP81720R109 81720R208 81720R505 81720R406 81720R604
LocationArizona; U.S.A
Business Address23460 North 19th
SectorPharmaceuticals
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.senestech.com
Phone928 779 4143
CurrencyUSD - US Dollar

SenesTech Key Financial Ratios

SenesTech Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets5.0M6.0M11.5M6.8M7.3M7.6M
Other Current Liab1.2M235K409K374K151K143.5K
Net Tangible Assets2.6M3.9M10.0M5.3M6.1M3.6M
Net Debt(982K)(2.2M)(8.8M)(4.4M)(5.0M)(5.2M)
Retained Earnings(95.9M)(104.2M)(112.5M)(122.2M)(129.9M)(136.4M)
Accounts Payable265K404K333K540K150K142.5K
Cash1.9M3.6M9.3M4.8M5.4M4.9M
Long Term Debt261K137K673K156K140.4K272.3K
Net Receivables149K25K77K113K95K73.5K
Other Current Assets277K206K252K378K388K269.2K
Total Liab2.4M2.1M1.5M1.5M942K894.9K
Short Long Term Debt123K98K32K33K29.7K28.2K
Total Current Assets3.5M4.8M10.7M6.1M6.7M6.6M
Short Term Debt123K98K196K360K467K424K
Common Stock16K24K1K5K12K6.6K
Long Term Debt Total591K261K137K673K774.0K419.8K
Capital Surpluse81.1M92.1M98.4M108.1M124.3M90.0M
Inventory1.2M945K1.0M853K795K911.9K

SenesTech Key Income Statement Accounts

The reason investors look at the income statement is to determine what SenesTech's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
201920202021202220232024 (projected)
Interest Expense42K28K11K2K4K3.8K
Total Revenue143K258K576K1.0M1.2M1.3M
Gross Profit42K(23K)220K464K539K566.0K
Operating Income(10.3M)(7.9M)(8.9M)(9.7M)(7.7M)(8.1M)
Ebit(10.3M)(7.9M)(8.3M)(9.7M)(7.7M)(8.1M)
Research Development1.9M1.5M2.0M1.9M1.2M2.2M
Ebitda(9.6M)(7.6M)(8.0M)(9.5M)(7.6M)(7.9M)
Cost Of Revenue101K281K356K555K654K621.3K
Income Before Tax(10.0M)(7.9M)(8.3M)(9.7M)(7.7M)(8.1M)
Net Income(10.3M)(7.7M)(8.0M)(9.7M)(7.7M)(8.1M)
Income Tax Expense308K(239K)(292K)19K26K24.7K
Interest Income45K3K4K7K22K35.2K
Net Interest Income3K(25K)(7K)5K21K22.1K

SenesTech Key Cash Accounts

201920202021202220232024 (projected)
Change To Inventory81K235K(56K)148K58K60.9K
Investments(71K)(67K)(99K)(170K)(121K)(127.1K)
Change In Cash(3.0M)1.7M5.7M(4.6M)620K420.2K
Net Borrowings(220K)511K(93K)(32K)(28.8K)(27.4K)
Free Cash Flow(8.1M)(7.2M)(7.9M)(8.8M)(7.7M)(8.1M)
Depreciation413K288K303K183K135K128.3K
Capital Expenditures71K114K100K174K149K203.7K
Net Income(10.0M)(7.9M)(8.3M)(9.7M)(7.7M)(8.1M)
End Period Cash Flow1.9M3.6M9.3M4.8M5.4M4.9M
Change To Netincome999K624K119K745K670.5K637.0K
Change Receivables(6K)(123K)(133K)124K142.6K149.7K

SenesTech Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining SenesTech's current stock value. Our valuation model uses many indicators to compare SenesTech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across SenesTech competition to find correlations between indicators driving SenesTech's intrinsic value. More Info.
JavaScript chart by amCharts 3.21.15NEUHWKNIOSPMTXKWRCCFSNES -1.2-1.0-0.8-0.6-0.4-0.200.2 -2.5-2.0-1.5-1.0-0.500.5
SenesTech is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . At this time, SenesTech's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value SenesTech by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

SenesTech Systematic Risk

SenesTech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. SenesTech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on SenesTech correlated with the market. If Beta is less than 0 SenesTech generally moves in the opposite direction as compared to the market. If SenesTech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one SenesTech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of SenesTech is generally in the same direction as the market. If Beta > 1 SenesTech moves generally in the same direction as, but more than the movement of the benchmark.
JavaScript chart by amCharts 3.21.15SepOctNovOct 28NovNov 11Nov 18Nov 25Dec2.42.62.83.0 20K40K60K80K100K120K140K 0.020.030.040.050.060.070.080.090.10 42K42.5K43K43.5K44K44.5K45K Show all
JavaScript chart by amCharts 3.21.15SenesTech Volume SenesTech Closing Prices Dow Jones Industrial Closing Prices - Benchmark SenesTech Beta
Today, most investors in SenesTech Stock are looking for potential investment opportunities by analyzing not only static indicators but also various SenesTech's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of SenesTech growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.0112

At this time, SenesTech's Price Earnings To Growth Ratio is comparatively stable compared to the past year.

SenesTech December 4, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of SenesTech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of SenesTech. We use our internally-developed statistical techniques to arrive at the intrinsic value of SenesTech based on widely used predictive technical indicators. In general, we focus on analyzing SenesTech Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build SenesTech's daily price indicators and compare them against related drivers.

Additional Tools for SenesTech Stock Analysis

When running SenesTech's price analysis, check to measure SenesTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SenesTech is operating at the current time. Most of SenesTech's value examination focuses on studying past and present price action to predict the probability of SenesTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SenesTech's price. Additionally, you may evaluate how the addition of SenesTech to your portfolios can decrease your overall portfolio volatility.